Our invention represents a new protocol for preparation of tolerogenic DCs with specific properties, induced only by extremely high concentrations of IFN-?. These cells represent potential tool for preparing therapeutic cellular drugs (regulatory T lymphocytes) used for treatment of different immunity-conditioned diseases.
F.33 Slovenian patent
COBISS.SI-ID: 9999999